Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IMAC Holdings, Inc. (BACK : OTC)

• Company Description    IMAC Holdings Inc. is a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids. It owns or manages outpatient clinics which provide regenerative, orthopedic and minimally invasive procedures and therapies. The company's outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. IMAC Holdings Inc. is based in BRENTWOOD TN. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.14 Daily Weekly Monthly 20 Day Moving Average: 82,487 shares Shares Outstanding: 2.07 (millions) Market Capitalization: $0.29 (millions) Beta: 2.00 52 Week High: $1.45 52 Week Low: $0.03 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -22.83% -22.70% 12 Week 90.27% 87.21% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3401 Mallory Lane Suite 100 - Franklin,TN 37067 USA ph: 844-266-4622 fax: - kgolodetz@lhai.com https://imacregeneration.gcs-web.com

• General Corporate Information    Officers Faith Zaslavsky - Chief Executive Officer and Director Sheri Gardzina - Chief Financial Officer Peter Beitsch - Director Jeffrey Busch - Director Maurice E. Evans - Director Peer Information IMAC Holdings, Inc. (CMTI) IMAC Holdings, Inc. (CMWLQ) IMAC Holdings, Inc. (AHG.) IMAC Holdings, Inc. (ROIX) IMAC Holdings, Inc. (M.DCE) IMAC Holdings, Inc. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 44967K302 SIC: 8093 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/13/26 Share - Related Items Shares Outstanding: 2.07 Most Recent Split Date: 9.00 (0.03:1) Beta: 2.00 Market Capitalization: $0.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 13.53% vs. Previous Quarter: -29.21% Sales Growth vs. Year Ago Period: -62.50% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -944.90 06/30/25 - -664.09 Current Ratio 12/31/25 - - 09/30/25 - 0.02 06/30/25 - 0.03 Quick Ratio 12/31/25 - - 09/30/25 - 0.02 06/30/25 - 0.03 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -42,273.92 06/30/25 - -15,096.55 Book Value 12/31/25 - - 09/30/25 - -6.26 06/30/25 - -4.74 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©